A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix — Christos Papadimitriou (1997) | RDL Network
MVAC is an active regimen in the treatment of patients with advanced or recurrent carcinoma of the uterine cervix. It produced responses in one-half of the patients in this study, and it can be administered on an outpatient basis. The addition of G-CSF appears to reduce hematologic toxicity.
Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos
Christos Papadimitriou, K. Sarris, Lia A. Moulopoulos, George Fountzilas, Athanassios Anagnostopoulos, Zannis Voulgaris, Dimitra Gika, Nikolaos Giannakoulis, Emmanuel Diakomanolis, Meletios A Dimopoulos
C Papadimitriou, Meletios A Dimopoulos, Nikolaos Giannakoulis, K. Sarris, Georgios Vassilakopoulos, T. Akrivos, Zannis Voulgaris, George Vlahos, Peter Athanassiadis
E. S. Papageorgiou, Panagiotis Tsirigotis, Meletios A Dimopoulos, Nikolaos Pavlidis, George Fountzilas, Sotirios G. Papageorgiou, Theofanis Economopoulos
Discussion(0)
No comments yet. Be the first to comment.